Shares of Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $60.22 and traded as low as $55.49. Novozymes A/S shares last traded at $58.72, with a volume of 9,063 shares changing hands.
Novozymes A/S Stock Performance
The business’s fifty day moving average price is $58.22 and its two-hundred day moving average price is $60.17. The firm has a market capitalization of $28.52 billion, a P/E ratio of 38.55, a PEG ratio of 3.87 and a beta of 0.91.
Novozymes A/S Increases Dividend
The company also recently announced a dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Monday, April 7th will be paid a $0.3758 dividend. This is an increase from Novozymes A/S’s previous dividend of $0.17. The ex-dividend date is Monday, April 7th. Novozymes A/S’s dividend payout ratio (DPR) is 94.94%.
Novozymes A/S Company Profile
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
Further Reading
- Five stocks we like better than Novozymes A/S
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Trading Halts Explained
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Investing in Travel Stocks Benefits
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.